BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21195977)

  • 1. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia.
    Lin YT; Jeng YY; Lin ML; Yu KW; Wang FD; Liu CY
    J Microbiol Immunol Infect; 2010 Dec; 43(6):498-505. PubMed ID: 21195977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient.
    Shah S; Sarwar U; King EA; Lat A
    Transpl Infect Dis; 2012 Aug; 14(4):398-402. PubMed ID: 22283924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit.
    Chou DW; Wu SL; Lee CT; Tai FT; Yu WL
    Jpn J Infect Dis; 2011; 64(6):520-4. PubMed ID: 22116334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
    Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY
    Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases.
    Chen FL; Wang GC; Teng SO; Ou TY; Yu FL; Lee WS
    J Microbiol Immunol Infect; 2013 Dec; 46(6):425-32. PubMed ID: 23022462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chryseobacterium indologenes bacteremia in an infant.
    Douvoyiannis M; Kalyoussef S; Philip G; Mayers MM
    Int J Infect Dis; 2010 Jun; 14(6):e531-2. PubMed ID: 19729329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality.
    Hung PP; Lin YH; Lin CF; Liu MF; Shi ZY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):137-44. PubMed ID: 18473101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia.
    Lin PY; Chen HL; Huang CT; Su LH; Chiu CH
    Int J Antimicrob Agents; 2010 Nov; 36(5):436-40. PubMed ID: 20933186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal case of community-acquired bacteremia and necrotizing fasciitis caused by Chryseobacterium meningosepticum: case report and review of the literature.
    Lee CC; Chen PL; Wang LR; Lee HC; Chang CM; Lee NY; Wu CJ; Shih HI; Ko WC
    J Clin Microbiol; 2006 Mar; 44(3):1181-3. PubMed ID: 16517926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chryseobacterium indologenes bacteraemia in a preterm baby.
    Sudharani V; ; Saxena NK
    Indian J Med Microbiol; 2011; 29(2):196-8. PubMed ID: 21654125
    [No Abstract]   [Full Text] [Related]  

  • 11. Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in Taiwan.
    Lin YT; Chan YJ; Chiu CH; Lin ML; Yu KW; Wang FD; Liu CY
    Int J Antimicrob Agents; 2009 Jul; 34(1):100-1. PubMed ID: 19261450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sepsis caused by Chryseobacterium indologenes in a patient with hydrocephalus].
    Ceylan A; Güdücüoğlu H; Akbayram S; Bektaş A; Berktaş M
    Mikrobiyol Bul; 2011 Oct; 45(4):735-40. PubMed ID: 22090305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumboperitonial shunt infection due to Chryseobacterium indologenes.
    Al-Tatari H; Asmar BI; Ang JY
    Pediatr Infect Dis J; 2007 Jul; 26(7):657-9. PubMed ID: 17596816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A severe form of Chryseobacterium indologenes pneumonia in an immunocompetent patient].
    Reynaud I; Chanteperdrix V; Broux C; Pavese P; Croizé J; Maurin M; Stahl JP; Jacquot C
    Med Mal Infect; 2007 Nov; 37(11):762-4. PubMed ID: 17888603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, epidemiological relatedness, and biofilm formation of clinical Chryseobacterium indologenes isolates from central Taiwan.
    Chang YC; Lo HH; Hsieh HY; Chang SM
    J Microbiol Immunol Infect; 2015 Oct; 48(5):559-64. PubMed ID: 24856421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myroides odoratus and Chryseobacterium indologenes: two rare isolates in the immunocompromised.
    Deepa R; Venkatesh KG; Parveen JD; Banu ST; Jayalakshmi G
    Indian J Med Microbiol; 2014; 32(3):327-30. PubMed ID: 25008832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of bla(IND) metallo-beta-lactamase-producing Chryseobacterium indologenes isolates detected in Hefei, China.
    Lin XH; Xu YH; Cheng J; Li T; Wang ZX
    Int J Antimicrob Agents; 2008 Nov; 32(5):398-400. PubMed ID: 18707850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
    Huang YC; Wu PF; Lin YT; Wang FD
    J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Central intravenous catheter-related bacteremia due to Chryseobacterium indologenes after cord blood transplantation].
    Kodama Y; Nishimura M; Nakashima K; Ito N; Fukano R; Okamura J; Inagaki J
    Rinsho Ketsueki; 2013 Mar; 54(3):305-10. PubMed ID: 23676648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six cases during 2012-2015 and literature review of Chryseobacterium indologenes infections in pediatric patients.
    Aykac K; Ozsurekci Y; Tuncer O; Sancak B; Cengiz AB; Kara A; Ceyhan M
    Can J Microbiol; 2016 Oct; 62(10):812-819. PubMed ID: 27397741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.